metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Non alcoholic fatty liver disease
Journal Information

Statistics

Follow this link to access the full text of the article

Non alcoholic fatty liver disease
Nahum Méndez-Sánchez
Corresponding author
nmendez@medicasur.org

Address for correspondence:
Read
696
Times
was read the article
264
Total PDF
432
Total HTML
Share statistics
 array:23 [
  "pii" => "S1665268119318198"
  "issn" => "16652681"
  "doi" => "10.1016/S1665-2681(19)31819-8"
  "estado" => "S300"
  "fechaPublicacion" => "2009-01-01"
  "aid" => "71481"
  "copyright" => "Fundación Clínica Médica Sur, A.C."
  "copyrightAnyo" => "2009"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "edi"
  "cita" => "Ann Hepatol. 2009;8 Supl 1:S3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 121
    "formatos" => array:3 [
      "EPUB" => 11
      "HTML" => 88
      "PDF" => 22
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1665268119318204"
    "issn" => "16652681"
    "doi" => "10.1016/S1665-2681(19)31820-4"
    "estado" => "S300"
    "fechaPublicacion" => "2009-01-01"
    "aid" => "71482"
    "copyright" => "Fundación Clínica Médica Sur, A.C."
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Ann Hepatol. 2009;8 Supl 1:S4-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 129
      "formatos" => array:3 [
        "EPUB" => 5
        "HTML" => 85
        "PDF" => 39
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "S4"
          "paginaFinal" => "S8"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Stefano Bellentani, Mariano Marino"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Stefano"
              "apellidos" => "Bellentani"
            ]
            1 => array:2 [
              "nombre" => "Mariano"
              "apellidos" => "Marino"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318204?idApp=UINPBA00004N"
    "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318204/v1_201906260858/en/main.assets"
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "Non alcoholic fatty liver disease"
    "subtitulo" => "<span class="elsevierStyleBold">Foreword</span>"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "S3"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Nahum M&#233;ndez-S&#225;nchez"
        "autores" => array:1 [
          0 => array:4 [
            "nombre" => "Nahum"
            "apellidos" => "M&#233;ndez-S&#225;nchez"
            "email" => array:1 [
              0 => "nmendez@medicasur.org"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor1"
              ]
            ]
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "&#42;"
            "correspondencia" => "Address for correspondence&#58;"
          ]
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="p0005" class="elsevierStylePara elsevierViewall">Non alcoholic fatty liver disease &#40;NAFLD&#41; is highly prevalent in Western countries as well as in some Latin American countries such as Brazil&#44; Chile and Mexico&#46; In fact&#44; it has been estimated that the prevalence of NAFLD ranged from 17 to 33&#37; in the general population of Western countries&#46;</p><p id="p0010" class="elsevierStylePara elsevierViewall">Besides&#44; it has been identified some ethnic differences in the epidemiology of NAFLD&#46; For example&#44; the prevalence of steatosis in United States&#44; assessed by magnetic resonance spectroscopy&#44; was highest in Hispanics &#40;45&#37;&#41;&#44; followed by whites &#40;33&#37;&#41;&#44; and African Americans &#40;24&#37;&#41;&#46; Interestingly&#44; the genetic variants contributing to differences in hepatic fat content have been identified in a recent study carried-out in a genome-wide association scan of nonsynonymous sequence variations&#46; This investigation found an allele in PNPLA3 &#40;rs738409&#91;G&#93;&#44; encoding I148M&#41; that was strongly associated with increased hepatic fat levels and with hepatic inflammation&#46; The allele was most common in Hispanics&#44; the group most susceptible to NAFLD&#46; This information clearly emphasizes the importance of NAFLD in this population&#46;</p><p id="p0015" class="elsevierStylePara elsevierViewall">On the other hand&#44; currently NAFLD is a recognized as a condition that ranges from simple steatosis to steatohepatitis &#40;NASH&#41;&#46; NASH is a more severe form of NAFLD in which fatty infiltration of the liver is accompanied by necroinflammatory activity&#44; and is now recognized as one of the most common cause of chronic liver disease&#46; The occurrence of NASH is clinically important as approximately 15&#8211;25&#37; of these patients will progress to cirrhosis&#46;</p><p id="p0020" class="elsevierStylePara elsevierViewall">In this supplement the epidemiology&#44; pathophysiology&#44; diagnosis&#44; treatment as well as other comor-bidities of NAFLD are carefully reviewed by some experimented researches in this field&#46;</p><p id="p0025" class="elsevierStylePara elsevierViewall">I am delighted to present the edition of the Symposium on Non-Alcoholic Fatty Liver Disease held at Medica Sur Clinic &#38; Foundation in Mexico City in October 3&#44; 2008&#46; I hope you will enjoy this thorough update of current knowledge in the field&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318198/v1_201906260858/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "78247"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Foreword"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/16652681/00000008000000S1/v1_201906260858/S1665268119318198/v1_201906260858/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318198?idApp=UINPBA00004N"
]
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 3 0 3
2024 October 14 2 16
2024 September 13 2 15
2024 August 16 2 18
2024 July 6 1 7
2024 June 11 2 13
2024 May 11 1 12
2024 April 5 2 7
2024 March 14 6 20
2024 February 13 3 16
2024 January 4 3 7
2023 December 4 3 7
2023 November 7 10 17
2023 October 8 3 11
2023 September 6 5 11
2023 August 4 1 5
2023 July 1 2 3
2023 June 5 3 8
2023 May 4 2 6
2023 April 4 2 6
2023 March 2 2 4
2023 February 3 3 6
2023 January 2 4 6
2022 December 5 1 6
2022 November 3 7 10
2022 October 7 4 11
2022 September 7 19 26
2022 August 7 15 22
2022 July 6 8 14
2022 June 6 8 14
2022 May 3 3 6
2022 April 5 7 12
2022 March 4 7 11
2022 February 6 5 11
2022 January 6 6 12
2021 December 3 8 11
2021 November 3 4 7
2021 October 5 8 13
2021 September 4 8 12
2021 August 4 6 10
2021 July 6 5 11
2021 June 8 5 13
2021 May 8 7 15
2021 April 12 8 20
2021 March 5 5 10
2021 February 1 3 4
2021 January 4 4 8
2020 December 2 2 4
2020 November 2 2 4
2020 October 4 0 4
2020 September 4 2 6
2020 August 8 3 11
2020 July 4 0 4
2020 June 4 1 5
2020 May 5 3 8
2020 April 4 2 6
2020 March 13 0 13
2020 February 13 4 17
2020 January 13 2 15
2019 December 11 4 15
2019 November 8 2 10
2019 October 8 1 9
2019 September 21 0 21
2019 August 14 1 15
2019 July 4 4 8
2019 June 2 6 8
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos